nodes	percent_of_prediction	percent_of_DWPC	metapath
Methsuximide—CYP2C19—Gliclazide—type 2 diabetes mellitus	0.118	0.197	CbGbCtD
Methsuximide—CYP2C19—Pioglitazone—type 2 diabetes mellitus	0.101	0.167	CbGbCtD
Methsuximide—CYP2C19—Chlorpropamide—type 2 diabetes mellitus	0.101	0.167	CbGbCtD
Methsuximide—CYP2C19—Rosiglitazone—type 2 diabetes mellitus	0.0929	0.155	CbGbCtD
Methsuximide—CYP2C19—Tolbutamide—type 2 diabetes mellitus	0.0898	0.149	CbGbCtD
Methsuximide—CYP2C19—Glyburide—type 2 diabetes mellitus	0.0516	0.0857	CbGbCtD
Methsuximide—CYP2C19—Losartan—type 2 diabetes mellitus	0.0472	0.0784	CbGbCtD
Methsuximide—Glutethimide—CYP11A1—type 2 diabetes mellitus	0.00169	0.201	CrCbGaD
Methsuximide—Aminophenazone—CYP1A2—type 2 diabetes mellitus	0.000827	0.0981	CrCbGaD
Methsuximide—Erythema multiforme—Gliclazide—type 2 diabetes mellitus	0.000825	0.00276	CcSEcCtD
Methsuximide—Rash—Acarbose—type 2 diabetes mellitus	0.000819	0.00274	CcSEcCtD
Methsuximide—Dermatitis—Acarbose—type 2 diabetes mellitus	0.000818	0.00273	CcSEcCtD
Methsuximide—Urticaria—Rosiglitazone—type 2 diabetes mellitus	0.000814	0.00272	CcSEcCtD
Methsuximide—Drowsiness—Metformin—type 2 diabetes mellitus	0.000813	0.00272	CcSEcCtD
Methsuximide—Insomnia—Glipizide—type 2 diabetes mellitus	0.000811	0.00271	CcSEcCtD
Methsuximide—Nausea—Chlorpropamide—type 2 diabetes mellitus	0.000803	0.00268	CcSEcCtD
Methsuximide—Nausea—Tolazamide—type 2 diabetes mellitus	0.000803	0.00268	CcSEcCtD
Methsuximide—Eosinophilia—Losartan—type 2 diabetes mellitus	0.000802	0.00268	CcSEcCtD
Methsuximide—Anorexia—Glimepiride—type 2 diabetes mellitus	0.000798	0.00267	CcSEcCtD
Methsuximide—Somnolence—Glipizide—type 2 diabetes mellitus	0.000797	0.00267	CcSEcCtD
Methsuximide—Vision blurred—Glyburide—type 2 diabetes mellitus	0.000797	0.00266	CcSEcCtD
Methsuximide—Vomiting—Nateglinide—type 2 diabetes mellitus	0.000796	0.00266	CcSEcCtD
Methsuximide—Rash—Nateglinide—type 2 diabetes mellitus	0.000789	0.00264	CcSEcCtD
Methsuximide—Dermatitis—Nateglinide—type 2 diabetes mellitus	0.000789	0.00264	CcSEcCtD
Methsuximide—Decreased appetite—Glipizide—type 2 diabetes mellitus	0.000779	0.00261	CcSEcCtD
Methsuximide—Insomnia—Pioglitazone—type 2 diabetes mellitus	0.000777	0.0026	CcSEcCtD
Methsuximide—Gastrointestinal disorder—Glipizide—type 2 diabetes mellitus	0.000774	0.00259	CcSEcCtD
Methsuximide—Nausea—Acarbose—type 2 diabetes mellitus	0.000771	0.00258	CcSEcCtD
Methsuximide—Constipation—Glipizide—type 2 diabetes mellitus	0.000767	0.00256	CcSEcCtD
Methsuximide—Confusional state—Bromocriptine—type 2 diabetes mellitus	0.000761	0.00254	CcSEcCtD
Methsuximide—Leukopenia—Glyburide—type 2 diabetes mellitus	0.000757	0.00253	CcSEcCtD
Methsuximide—Insomnia—Glimepiride—type 2 diabetes mellitus	0.000757	0.00253	CcSEcCtD
Methsuximide—Insomnia—Sitagliptin—type 2 diabetes mellitus	0.000754	0.00252	CcSEcCtD
Methsuximide—Tension—Gliclazide—type 2 diabetes mellitus	0.000745	0.00249	CcSEcCtD
Methsuximide—Somnolence—Glimepiride—type 2 diabetes mellitus	0.000744	0.00249	CcSEcCtD
Methsuximide—Nausea—Nateglinide—type 2 diabetes mellitus	0.000744	0.00249	CcSEcCtD
Methsuximide—Gastrointestinal disorder—Pioglitazone—type 2 diabetes mellitus	0.000742	0.00248	CcSEcCtD
Methsuximide—Somnolence—Sitagliptin—type 2 diabetes mellitus	0.000741	0.00248	CcSEcCtD
Methsuximide—Diarrhoea—Repaglinide—type 2 diabetes mellitus	0.000741	0.00248	CcSEcCtD
Methsuximide—Feeling abnormal—Glipizide—type 2 diabetes mellitus	0.000739	0.00247	CcSEcCtD
Methsuximide—Nervousness—Gliclazide—type 2 diabetes mellitus	0.000737	0.00247	CcSEcCtD
Methsuximide—Gastrointestinal pain—Glipizide—type 2 diabetes mellitus	0.000733	0.00245	CcSEcCtD
Methsuximide—Decreased appetite—Glimepiride—type 2 diabetes mellitus	0.000727	0.00243	CcSEcCtD
Methsuximide—Decreased appetite—Sitagliptin—type 2 diabetes mellitus	0.000725	0.00242	CcSEcCtD
Methsuximide—Gastrointestinal disorder—Glimepiride—type 2 diabetes mellitus	0.000722	0.00242	CcSEcCtD
Methsuximide—Gastrointestinal disorder—Sitagliptin—type 2 diabetes mellitus	0.00072	0.00241	CcSEcCtD
Methsuximide—Anorexia—Bromocriptine—type 2 diabetes mellitus	0.00072	0.00241	CcSEcCtD
Methsuximide—Stevens-Johnson syndrome—Losartan—type 2 diabetes mellitus	0.000716	0.00239	CcSEcCtD
Methsuximide—Constipation—Sitagliptin—type 2 diabetes mellitus	0.000713	0.00238	CcSEcCtD
Methsuximide—Urticaria—Glipizide—type 2 diabetes mellitus	0.000712	0.00238	CcSEcCtD
Methsuximide—Abdominal pain—Glipizide—type 2 diabetes mellitus	0.000709	0.00237	CcSEcCtD
Methsuximide—Feeling abnormal—Pioglitazone—type 2 diabetes mellitus	0.000708	0.00237	CcSEcCtD
Methsuximide—Diarrhoea—Rosiglitazone—type 2 diabetes mellitus	0.000701	0.00234	CcSEcCtD
Methsuximide—Confusional state—Glyburide—type 2 diabetes mellitus	0.000696	0.00233	CcSEcCtD
Methsuximide—Feeling abnormal—Glimepiride—type 2 diabetes mellitus	0.000689	0.00231	CcSEcCtD
Methsuximide—Vomiting—Repaglinide—type 2 diabetes mellitus	0.000689	0.0023	CcSEcCtD
Methsuximide—Eosinophilia—Ramipril—type 2 diabetes mellitus	0.000687	0.0023	CcSEcCtD
Methsuximide—Feeling abnormal—Sitagliptin—type 2 diabetes mellitus	0.000687	0.0023	CcSEcCtD
Methsuximide—Gastrointestinal pain—Glimepiride—type 2 diabetes mellitus	0.000684	0.00229	CcSEcCtD
Methsuximide—Rash—Repaglinide—type 2 diabetes mellitus	0.000683	0.00228	CcSEcCtD
Methsuximide—Insomnia—Bromocriptine—type 2 diabetes mellitus	0.000683	0.00228	CcSEcCtD
Methsuximide—Dermatitis—Repaglinide—type 2 diabetes mellitus	0.000683	0.00228	CcSEcCtD
Methsuximide—Urticaria—Pioglitazone—type 2 diabetes mellitus	0.000682	0.00228	CcSEcCtD
Methsuximide—Gastrointestinal pain—Sitagliptin—type 2 diabetes mellitus	0.000682	0.00228	CcSEcCtD
Methsuximide—Leukopenia—Gliclazide—type 2 diabetes mellitus	0.00068	0.00227	CcSEcCtD
Methsuximide—Headache—Repaglinide—type 2 diabetes mellitus	0.000679	0.00227	CcSEcCtD
Methsuximide—Dizziness—Rosiglitazone—type 2 diabetes mellitus	0.000677	0.00226	CcSEcCtD
Methsuximide—Somnolence—Bromocriptine—type 2 diabetes mellitus	0.000671	0.00224	CcSEcCtD
Methsuximide—Urticaria—Glimepiride—type 2 diabetes mellitus	0.000665	0.00222	CcSEcCtD
Methsuximide—Urticaria—Sitagliptin—type 2 diabetes mellitus	0.000663	0.00222	CcSEcCtD
Methsuximide—Abdominal pain—Glimepiride—type 2 diabetes mellitus	0.000661	0.00221	CcSEcCtD
Methsuximide—Abdominal pain—Sitagliptin—type 2 diabetes mellitus	0.000659	0.0022	CcSEcCtD
Methsuximide—Pancytopenia—Ramipril—type 2 diabetes mellitus	0.000659	0.0022	CcSEcCtD
Methsuximide—Anorexia—Glyburide—type 2 diabetes mellitus	0.000658	0.0022	CcSEcCtD
Methsuximide—Vision blurred—Valsartan—type 2 diabetes mellitus	0.000657	0.0022	CcSEcCtD
Methsuximide—Decreased appetite—Bromocriptine—type 2 diabetes mellitus	0.000656	0.00219	CcSEcCtD
Methsuximide—Gastrointestinal disorder—Bromocriptine—type 2 diabetes mellitus	0.000652	0.00218	CcSEcCtD
Methsuximide—Vision blurred—Orlistat—type 2 diabetes mellitus	0.00065	0.00217	CcSEcCtD
Methsuximide—Rash—Rosiglitazone—type 2 diabetes mellitus	0.000646	0.00216	CcSEcCtD
Methsuximide—Constipation—Bromocriptine—type 2 diabetes mellitus	0.000645	0.00216	CcSEcCtD
Methsuximide—Dermatitis—Rosiglitazone—type 2 diabetes mellitus	0.000645	0.00216	CcSEcCtD
Methsuximide—Nausea—Repaglinide—type 2 diabetes mellitus	0.000644	0.00215	CcSEcCtD
Methsuximide—Headache—Rosiglitazone—type 2 diabetes mellitus	0.000642	0.00215	CcSEcCtD
Methsuximide—Confusional state—Gliclazide—type 2 diabetes mellitus	0.000625	0.00209	CcSEcCtD
Methsuximide—Feeling abnormal—Bromocriptine—type 2 diabetes mellitus	0.000622	0.00208	CcSEcCtD
Methsuximide—Gastrointestinal pain—Bromocriptine—type 2 diabetes mellitus	0.000617	0.00206	CcSEcCtD
Methsuximide—Stevens-Johnson syndrome—Ramipril—type 2 diabetes mellitus	0.000614	0.00205	CcSEcCtD
Methsuximide—Diarrhoea—Glipizide—type 2 diabetes mellitus	0.000613	0.00205	CcSEcCtD
Methsuximide—Erythema multiforme—Losartan—type 2 diabetes mellitus	0.000613	0.00205	CcSEcCtD
Methsuximide—Nausea—Rosiglitazone—type 2 diabetes mellitus	0.000608	0.00203	CcSEcCtD
Methsuximide—Decreased appetite—Glyburide—type 2 diabetes mellitus	0.0006	0.00201	CcSEcCtD
Methsuximide—Urticaria—Bromocriptine—type 2 diabetes mellitus	0.0006	0.002	CcSEcCtD
Methsuximide—Vision blurred—Metformin—type 2 diabetes mellitus	0.000599	0.002	CcSEcCtD
Methsuximide—Abdominal pain—Bromocriptine—type 2 diabetes mellitus	0.000597	0.002	CcSEcCtD
Methsuximide—Gastrointestinal disorder—Glyburide—type 2 diabetes mellitus	0.000596	0.00199	CcSEcCtD
Methsuximide—Dizziness—Glipizide—type 2 diabetes mellitus	0.000593	0.00198	CcSEcCtD
Methsuximide—Tension—Irbesartan—type 2 diabetes mellitus	0.000588	0.00197	CcSEcCtD
Methsuximide—Diarrhoea—Pioglitazone—type 2 diabetes mellitus	0.000588	0.00197	CcSEcCtD
Methsuximide—Nervousness—Irbesartan—type 2 diabetes mellitus	0.000582	0.00195	CcSEcCtD
Methsuximide—Diarrhoea—Glimepiride—type 2 diabetes mellitus	0.000572	0.00191	CcSEcCtD
Methsuximide—Diarrhoea—Sitagliptin—type 2 diabetes mellitus	0.000571	0.00191	CcSEcCtD
Methsuximide—Vomiting—Glipizide—type 2 diabetes mellitus	0.00057	0.00191	CcSEcCtD
Methsuximide—Feeling abnormal—Glyburide—type 2 diabetes mellitus	0.000569	0.0019	CcSEcCtD
Methsuximide—Dizziness—Pioglitazone—type 2 diabetes mellitus	0.000568	0.0019	CcSEcCtD
Methsuximide—Rash—Glipizide—type 2 diabetes mellitus	0.000565	0.00189	CcSEcCtD
Methsuximide—Vision blurred—Irbesartan—type 2 diabetes mellitus	0.000565	0.00189	CcSEcCtD
Methsuximide—Dermatitis—Glipizide—type 2 diabetes mellitus	0.000565	0.00189	CcSEcCtD
Methsuximide—Gastrointestinal pain—Glyburide—type 2 diabetes mellitus	0.000564	0.00189	CcSEcCtD
Methsuximide—Headache—Glipizide—type 2 diabetes mellitus	0.000562	0.00188	CcSEcCtD
Methsuximide—Insomnia—Gliclazide—type 2 diabetes mellitus	0.00056	0.00187	CcSEcCtD
Methsuximide—Tension—Losartan—type 2 diabetes mellitus	0.000554	0.00185	CcSEcCtD
Methsuximide—Dizziness—Glimepiride—type 2 diabetes mellitus	0.000553	0.00185	CcSEcCtD
Methsuximide—Dizziness—Sitagliptin—type 2 diabetes mellitus	0.000552	0.00184	CcSEcCtD
Methsuximide—Somnolence—Gliclazide—type 2 diabetes mellitus	0.000551	0.00184	CcSEcCtD
Methsuximide—Urticaria—Glyburide—type 2 diabetes mellitus	0.000548	0.00183	CcSEcCtD
Methsuximide—Nervousness—Losartan—type 2 diabetes mellitus	0.000548	0.00183	CcSEcCtD
Methsuximide—Aminophenazone—CYP3A4—type 2 diabetes mellitus	0.000547	0.0649	CrCbGaD
Methsuximide—Antipyrine—CYP2E1—type 2 diabetes mellitus	0.000547	0.0649	CrCbGaD
Methsuximide—Abdominal pain—Glyburide—type 2 diabetes mellitus	0.000545	0.00182	CcSEcCtD
Methsuximide—Anorexia—Valsartan—type 2 diabetes mellitus	0.000543	0.00181	CcSEcCtD
Methsuximide—Headache—Pioglitazone—type 2 diabetes mellitus	0.000538	0.0018	CcSEcCtD
Methsuximide—Leukopenia—Irbesartan—type 2 diabetes mellitus	0.000537	0.00179	CcSEcCtD
Methsuximide—Gastrointestinal disorder—Gliclazide—type 2 diabetes mellitus	0.000535	0.00179	CcSEcCtD
Methsuximide—Nausea—Glipizide—type 2 diabetes mellitus	0.000533	0.00178	CcSEcCtD
Methsuximide—Vomiting—Glimepiride—type 2 diabetes mellitus	0.000532	0.00178	CcSEcCtD
Methsuximide—Vision blurred—Losartan—type 2 diabetes mellitus	0.000532	0.00178	CcSEcCtD
Methsuximide—Vomiting—Sitagliptin—type 2 diabetes mellitus	0.00053	0.00177	CcSEcCtD
Methsuximide—Constipation—Gliclazide—type 2 diabetes mellitus	0.00053	0.00177	CcSEcCtD
Methsuximide—Rash—Glimepiride—type 2 diabetes mellitus	0.000528	0.00176	CcSEcCtD
Methsuximide—Dermatitis—Glimepiride—type 2 diabetes mellitus	0.000527	0.00176	CcSEcCtD
Methsuximide—Rash—Sitagliptin—type 2 diabetes mellitus	0.000526	0.00176	CcSEcCtD
Methsuximide—Dermatitis—Sitagliptin—type 2 diabetes mellitus	0.000525	0.00176	CcSEcCtD
Methsuximide—Erythema multiforme—Ramipril—type 2 diabetes mellitus	0.000525	0.00176	CcSEcCtD
Methsuximide—Headache—Glimepiride—type 2 diabetes mellitus	0.000524	0.00175	CcSEcCtD
Methsuximide—Headache—Sitagliptin—type 2 diabetes mellitus	0.000523	0.00175	CcSEcCtD
Methsuximide—Antipyrine—CYP1A2—type 2 diabetes mellitus	0.00052	0.0617	CrCbGaD
Methsuximide—Diarrhoea—Bromocriptine—type 2 diabetes mellitus	0.000516	0.00173	CcSEcCtD
Methsuximide—Insomnia—Valsartan—type 2 diabetes mellitus	0.000515	0.00172	CcSEcCtD
Methsuximide—Feeling abnormal—Gliclazide—type 2 diabetes mellitus	0.000511	0.00171	CcSEcCtD
Methsuximide—Insomnia—Orlistat—type 2 diabetes mellitus	0.000509	0.0017	CcSEcCtD
Methsuximide—Gastrointestinal pain—Gliclazide—type 2 diabetes mellitus	0.000507	0.00169	CcSEcCtD
Methsuximide—Somnolence—Valsartan—type 2 diabetes mellitus	0.000506	0.00169	CcSEcCtD
Methsuximide—Leukopenia—Losartan—type 2 diabetes mellitus	0.000505	0.00169	CcSEcCtD
Methsuximide—Dizziness—Bromocriptine—type 2 diabetes mellitus	0.000499	0.00167	CcSEcCtD
Methsuximide—Nausea—Glimepiride—type 2 diabetes mellitus	0.000497	0.00166	CcSEcCtD
Methsuximide—Nausea—Sitagliptin—type 2 diabetes mellitus	0.000495	0.00166	CcSEcCtD
Methsuximide—Decreased appetite—Valsartan—type 2 diabetes mellitus	0.000495	0.00165	CcSEcCtD
Methsuximide—Anorexia—Metformin—type 2 diabetes mellitus	0.000494	0.00165	CcSEcCtD
Methsuximide—Urticaria—Gliclazide—type 2 diabetes mellitus	0.000492	0.00165	CcSEcCtD
Methsuximide—Gastrointestinal disorder—Valsartan—type 2 diabetes mellitus	0.000491	0.00164	CcSEcCtD
Methsuximide—Abdominal pain—Gliclazide—type 2 diabetes mellitus	0.00049	0.00164	CcSEcCtD
Methsuximide—Decreased appetite—Orlistat—type 2 diabetes mellitus	0.000489	0.00163	CcSEcCtD
Methsuximide—Constipation—Valsartan—type 2 diabetes mellitus	0.000487	0.00163	CcSEcCtD
Methsuximide—Gastrointestinal disorder—Orlistat—type 2 diabetes mellitus	0.000486	0.00162	CcSEcCtD
Methsuximide—Vomiting—Bromocriptine—type 2 diabetes mellitus	0.00048	0.0016	CcSEcCtD
Methsuximide—Rash—Bromocriptine—type 2 diabetes mellitus	0.000476	0.00159	CcSEcCtD
Methsuximide—Dermatitis—Bromocriptine—type 2 diabetes mellitus	0.000475	0.00159	CcSEcCtD
Methsuximide—Tension—Ramipril—type 2 diabetes mellitus	0.000475	0.00159	CcSEcCtD
Methsuximide—Headache—Bromocriptine—type 2 diabetes mellitus	0.000473	0.00158	CcSEcCtD
Methsuximide—Diarrhoea—Glyburide—type 2 diabetes mellitus	0.000472	0.00158	CcSEcCtD
Methsuximide—Nervousness—Ramipril—type 2 diabetes mellitus	0.00047	0.00157	CcSEcCtD
Methsuximide—Anorexia—Irbesartan—type 2 diabetes mellitus	0.000466	0.00156	CcSEcCtD
Methsuximide—Gastrointestinal pain—Valsartan—type 2 diabetes mellitus	0.000465	0.00156	CcSEcCtD
Methsuximide—Confusional state—Losartan—type 2 diabetes mellitus	0.000464	0.00155	CcSEcCtD
Methsuximide—Feeling abnormal—Orlistat—type 2 diabetes mellitus	0.000464	0.00155	CcSEcCtD
Methsuximide—Somnolence—Metformin—type 2 diabetes mellitus	0.000461	0.00154	CcSEcCtD
Methsuximide—Gastrointestinal pain—Orlistat—type 2 diabetes mellitus	0.00046	0.00154	CcSEcCtD
Methsuximide—Urticaria—Valsartan—type 2 diabetes mellitus	0.000452	0.00151	CcSEcCtD
Methsuximide—Decreased appetite—Metformin—type 2 diabetes mellitus	0.000451	0.00151	CcSEcCtD
Methsuximide—Abdominal pain—Valsartan—type 2 diabetes mellitus	0.00045	0.0015	CcSEcCtD
Methsuximide—Nausea—Bromocriptine—type 2 diabetes mellitus	0.000448	0.0015	CcSEcCtD
Methsuximide—Gastrointestinal disorder—Metformin—type 2 diabetes mellitus	0.000448	0.0015	CcSEcCtD
Methsuximide—Urticaria—Orlistat—type 2 diabetes mellitus	0.000447	0.00149	CcSEcCtD
Methsuximide—Abdominal pain—Orlistat—type 2 diabetes mellitus	0.000445	0.00149	CcSEcCtD
Methsuximide—Constipation—Metformin—type 2 diabetes mellitus	0.000443	0.00148	CcSEcCtD
Methsuximide—Anorexia—Losartan—type 2 diabetes mellitus	0.000439	0.00147	CcSEcCtD
Methsuximide—Vomiting—Glyburide—type 2 diabetes mellitus	0.000439	0.00147	CcSEcCtD
Methsuximide—Rash—Glyburide—type 2 diabetes mellitus	0.000435	0.00145	CcSEcCtD
Methsuximide—Somnolence—Irbesartan—type 2 diabetes mellitus	0.000435	0.00145	CcSEcCtD
Methsuximide—Dermatitis—Glyburide—type 2 diabetes mellitus	0.000435	0.00145	CcSEcCtD
Methsuximide—Leukopenia—Ramipril—type 2 diabetes mellitus	0.000433	0.00145	CcSEcCtD
Methsuximide—Headache—Glyburide—type 2 diabetes mellitus	0.000432	0.00145	CcSEcCtD
Methsuximide—Feeling abnormal—Metformin—type 2 diabetes mellitus	0.000427	0.00143	CcSEcCtD
Methsuximide—Decreased appetite—Irbesartan—type 2 diabetes mellitus	0.000425	0.00142	CcSEcCtD
Methsuximide—Diarrhoea—Gliclazide—type 2 diabetes mellitus	0.000424	0.00142	CcSEcCtD
Methsuximide—Gastrointestinal pain—Metformin—type 2 diabetes mellitus	0.000424	0.00142	CcSEcCtD
Methsuximide—Gastrointestinal disorder—Irbesartan—type 2 diabetes mellitus	0.000422	0.00141	CcSEcCtD
Methsuximide—Constipation—Irbesartan—type 2 diabetes mellitus	0.000418	0.0014	CcSEcCtD
Methsuximide—Insomnia—Losartan—type 2 diabetes mellitus	0.000416	0.00139	CcSEcCtD
Methsuximide—Urticaria—Metformin—type 2 diabetes mellitus	0.000412	0.00138	CcSEcCtD
Methsuximide—Nausea—Glyburide—type 2 diabetes mellitus	0.00041	0.00137	CcSEcCtD
Methsuximide—Abdominal pain—Metformin—type 2 diabetes mellitus	0.00041	0.00137	CcSEcCtD
Methsuximide—Dizziness—Gliclazide—type 2 diabetes mellitus	0.00041	0.00137	CcSEcCtD
Methsuximide—Somnolence—Losartan—type 2 diabetes mellitus	0.000409	0.00137	CcSEcCtD
Methsuximide—Feeling abnormal—Irbesartan—type 2 diabetes mellitus	0.000403	0.00135	CcSEcCtD
Methsuximide—Primidone—CYP1A2—type 2 diabetes mellitus	0.000403	0.0478	CrCbGaD
Methsuximide—Decreased appetite—Losartan—type 2 diabetes mellitus	0.0004	0.00134	CcSEcCtD
Methsuximide—Gastrointestinal pain—Irbesartan—type 2 diabetes mellitus	0.0004	0.00134	CcSEcCtD
Methsuximide—Confusional state—Ramipril—type 2 diabetes mellitus	0.000398	0.00133	CcSEcCtD
Methsuximide—Phenytoin—ABCC2—type 2 diabetes mellitus	0.000397	0.0471	CrCbGaD
Methsuximide—Vomiting—Gliclazide—type 2 diabetes mellitus	0.000394	0.00132	CcSEcCtD
Methsuximide—Constipation—Losartan—type 2 diabetes mellitus	0.000394	0.00132	CcSEcCtD
Methsuximide—Rash—Gliclazide—type 2 diabetes mellitus	0.000391	0.00131	CcSEcCtD
Methsuximide—Dermatitis—Gliclazide—type 2 diabetes mellitus	0.00039	0.00131	CcSEcCtD
Methsuximide—Diarrhoea—Valsartan—type 2 diabetes mellitus	0.000389	0.0013	CcSEcCtD
Methsuximide—Urticaria—Irbesartan—type 2 diabetes mellitus	0.000389	0.0013	CcSEcCtD
Methsuximide—Headache—Gliclazide—type 2 diabetes mellitus	0.000388	0.0013	CcSEcCtD
Methsuximide—Abdominal pain—Irbesartan—type 2 diabetes mellitus	0.000387	0.00129	CcSEcCtD
Methsuximide—Diarrhoea—Orlistat—type 2 diabetes mellitus	0.000385	0.00129	CcSEcCtD
Methsuximide—Phenobarbital—ABCC2—type 2 diabetes mellitus	0.000381	0.0452	CrCbGaD
Methsuximide—Feeling abnormal—Losartan—type 2 diabetes mellitus	0.000379	0.00127	CcSEcCtD
Methsuximide—Gastrointestinal pain—Losartan—type 2 diabetes mellitus	0.000376	0.00126	CcSEcCtD
Methsuximide—Dizziness—Valsartan—type 2 diabetes mellitus	0.000376	0.00126	CcSEcCtD
Methsuximide—Anorexia—Ramipril—type 2 diabetes mellitus	0.000376	0.00126	CcSEcCtD
Methsuximide—Dizziness—Orlistat—type 2 diabetes mellitus	0.000372	0.00124	CcSEcCtD
Methsuximide—Nausea—Gliclazide—type 2 diabetes mellitus	0.000368	0.00123	CcSEcCtD
Methsuximide—Urticaria—Losartan—type 2 diabetes mellitus	0.000366	0.00122	CcSEcCtD
Methsuximide—Abdominal pain—Losartan—type 2 diabetes mellitus	0.000364	0.00122	CcSEcCtD
Methsuximide—Vomiting—Valsartan—type 2 diabetes mellitus	0.000362	0.00121	CcSEcCtD
Methsuximide—Rash—Valsartan—type 2 diabetes mellitus	0.000359	0.0012	CcSEcCtD
Methsuximide—Dermatitis—Valsartan—type 2 diabetes mellitus	0.000359	0.0012	CcSEcCtD
Methsuximide—Vomiting—Orlistat—type 2 diabetes mellitus	0.000358	0.0012	CcSEcCtD
Methsuximide—Insomnia—Ramipril—type 2 diabetes mellitus	0.000357	0.00119	CcSEcCtD
Methsuximide—CACNA1H—NCAM signaling for neurite out-growth—SRC—type 2 diabetes mellitus	0.000357	0.00391	CbGpPWpGaD
Methsuximide—Headache—Valsartan—type 2 diabetes mellitus	0.000357	0.00119	CcSEcCtD
Methsuximide—CACNA1H—Corticotropin-releasing hormone—RELA—type 2 diabetes mellitus	0.000356	0.00391	CbGpPWpGaD
Methsuximide—Diarrhoea—Metformin—type 2 diabetes mellitus	0.000355	0.00119	CcSEcCtD
Methsuximide—Rash—Orlistat—type 2 diabetes mellitus	0.000355	0.00119	CcSEcCtD
Methsuximide—Dermatitis—Orlistat—type 2 diabetes mellitus	0.000354	0.00118	CcSEcCtD
Methsuximide—Headache—Orlistat—type 2 diabetes mellitus	0.000352	0.00118	CcSEcCtD
Methsuximide—Somnolence—Ramipril—type 2 diabetes mellitus	0.000351	0.00117	CcSEcCtD
Methsuximide—CACNA1G—Regulation of nuclear beta catenin signaling and target gene transcription—MMP9—type 2 diabetes mellitus	0.000351	0.00385	CbGpPWpGaD
Methsuximide—CACNA1H—Axon guidance—TRPC6—type 2 diabetes mellitus	0.00035	0.00384	CbGpPWpGaD
Methsuximide—CACNA1I—Developmental Biology—TRPC6—type 2 diabetes mellitus	0.00035	0.00384	CbGpPWpGaD
Methsuximide—CACNA1H—Developmental Biology—HNF1B—type 2 diabetes mellitus	0.000349	0.00382	CbGpPWpGaD
Methsuximide—Antipyrine—CYP3A4—type 2 diabetes mellitus	0.000345	0.0409	CrCbGaD
Methsuximide—Decreased appetite—Ramipril—type 2 diabetes mellitus	0.000343	0.00115	CcSEcCtD
Methsuximide—Dizziness—Metformin—type 2 diabetes mellitus	0.000343	0.00115	CcSEcCtD
Methsuximide—Gastrointestinal disorder—Ramipril—type 2 diabetes mellitus	0.000341	0.00114	CcSEcCtD
Methsuximide—Nausea—Valsartan—type 2 diabetes mellitus	0.000338	0.00113	CcSEcCtD
Methsuximide—Constipation—Ramipril—type 2 diabetes mellitus	0.000338	0.00113	CcSEcCtD
Methsuximide—Antipyrine—PTGS2—type 2 diabetes mellitus	0.000337	0.04	CrCbGaD
Methsuximide—CACNA1I—NCAM signaling for neurite out-growth—IL6—type 2 diabetes mellitus	0.000337	0.00369	CbGpPWpGaD
Methsuximide—CACNA1I—Developmental Biology—PAX6—type 2 diabetes mellitus	0.000335	0.00367	CbGpPWpGaD
Methsuximide—Diarrhoea—Irbesartan—type 2 diabetes mellitus	0.000335	0.00112	CcSEcCtD
Methsuximide—Nausea—Orlistat—type 2 diabetes mellitus	0.000334	0.00112	CcSEcCtD
Methsuximide—Vomiting—Metformin—type 2 diabetes mellitus	0.00033	0.0011	CcSEcCtD
Methsuximide—Rash—Metformin—type 2 diabetes mellitus	0.000327	0.00109	CcSEcCtD
Methsuximide—Dermatitis—Metformin—type 2 diabetes mellitus	0.000327	0.00109	CcSEcCtD
Methsuximide—Feeling abnormal—Ramipril—type 2 diabetes mellitus	0.000325	0.00109	CcSEcCtD
Methsuximide—Headache—Metformin—type 2 diabetes mellitus	0.000325	0.00109	CcSEcCtD
Methsuximide—CYP2C19—Melatonin metabolism and effects—EDN1—type 2 diabetes mellitus	0.000324	0.00355	CbGpPWpGaD
Methsuximide—CACNA1I—Developmental Biology—SREBF1—type 2 diabetes mellitus	0.000324	0.00355	CbGpPWpGaD
Methsuximide—Dizziness—Irbesartan—type 2 diabetes mellitus	0.000324	0.00108	CcSEcCtD
Methsuximide—Gastrointestinal pain—Ramipril—type 2 diabetes mellitus	0.000323	0.00108	CcSEcCtD
Methsuximide—CACNA1H—Corticotropin-releasing hormone—CASP3—type 2 diabetes mellitus	0.000321	0.00352	CbGpPWpGaD
Methsuximide—CYP2C19—Constitutive Androstane Receptor Pathway—PPARGC1A—type 2 diabetes mellitus	0.000319	0.0035	CbGpPWpGaD
Methsuximide—Diarrhoea—Losartan—type 2 diabetes mellitus	0.000315	0.00105	CcSEcCtD
Methsuximide—Urticaria—Ramipril—type 2 diabetes mellitus	0.000314	0.00105	CcSEcCtD
Methsuximide—Abdominal pain—Ramipril—type 2 diabetes mellitus	0.000312	0.00104	CcSEcCtD
Methsuximide—Vomiting—Irbesartan—type 2 diabetes mellitus	0.000311	0.00104	CcSEcCtD
Methsuximide—Rash—Irbesartan—type 2 diabetes mellitus	0.000308	0.00103	CcSEcCtD
Methsuximide—Dermatitis—Irbesartan—type 2 diabetes mellitus	0.000308	0.00103	CcSEcCtD
Methsuximide—Nausea—Metformin—type 2 diabetes mellitus	0.000308	0.00103	CcSEcCtD
Methsuximide—Headache—Irbesartan—type 2 diabetes mellitus	0.000306	0.00102	CcSEcCtD
Methsuximide—Dizziness—Losartan—type 2 diabetes mellitus	0.000304	0.00102	CcSEcCtD
Methsuximide—CACNA1H—Corticotropin-releasing hormone—NFKB1—type 2 diabetes mellitus	0.000301	0.0033	CbGpPWpGaD
Methsuximide—CACNA1I—Developmental Biology—ADIPOQ—type 2 diabetes mellitus	0.000297	0.00326	CbGpPWpGaD
Methsuximide—Vomiting—Losartan—type 2 diabetes mellitus	0.000293	0.000979	CcSEcCtD
Methsuximide—Nausea—Irbesartan—type 2 diabetes mellitus	0.000291	0.000972	CcSEcCtD
Methsuximide—Rash—Losartan—type 2 diabetes mellitus	0.00029	0.000971	CcSEcCtD
Methsuximide—Dermatitis—Losartan—type 2 diabetes mellitus	0.00029	0.00097	CcSEcCtD
Methsuximide—Headache—Losartan—type 2 diabetes mellitus	0.000288	0.000964	CcSEcCtD
Methsuximide—CYP2C19—Cytochrome P450 - arranged by substrate type—CYP11A1—type 2 diabetes mellitus	0.000286	0.00314	CbGpPWpGaD
Methsuximide—CYP2C19—Oxidation by Cytochrome P450—CYP11A1—type 2 diabetes mellitus	0.000283	0.0031	CbGpPWpGaD
Methsuximide—CACNA1I—Developmental Biology—SLC2A4—type 2 diabetes mellitus	0.000281	0.00308	CbGpPWpGaD
Methsuximide—CACNA1G—Developmental Biology—SLC2A2—type 2 diabetes mellitus	0.000279	0.00305	CbGpPWpGaD
Methsuximide—Nausea—Losartan—type 2 diabetes mellitus	0.000273	0.000914	CcSEcCtD
Methsuximide—CACNA1G—Developmental Biology—HNF4A—type 2 diabetes mellitus	0.000273	0.00299	CbGpPWpGaD
Methsuximide—Ketazolam—CYP3A4—type 2 diabetes mellitus	0.000272	0.0323	CrCbGaD
Methsuximide—CYP2C19—Arachidonic acid metabolism—CYP1A2—type 2 diabetes mellitus	0.00027	0.00296	CbGpPWpGaD
Methsuximide—Diarrhoea—Ramipril—type 2 diabetes mellitus	0.00027	0.000903	CcSEcCtD
Methsuximide—CACNA1H—Developmental Biology—SLC2A2—type 2 diabetes mellitus	0.00027	0.00296	CbGpPWpGaD
Methsuximide—Phenobarbital—CYP2E1—type 2 diabetes mellitus	0.000267	0.0317	CrCbGaD
Methsuximide—Primidone—CYP3A4—type 2 diabetes mellitus	0.000267	0.0316	CrCbGaD
Methsuximide—CACNA1G—Developmental Biology—GCK—type 2 diabetes mellitus	0.000266	0.00292	CbGpPWpGaD
Methsuximide—CYP2C19—Melatonin metabolism and effects—CALM1—type 2 diabetes mellitus	0.000265	0.0029	CbGpPWpGaD
Methsuximide—CACNA1G—Developmental Biology—IAPP—type 2 diabetes mellitus	0.000264	0.0029	CbGpPWpGaD
Methsuximide—CACNA1H—Developmental Biology—HNF4A—type 2 diabetes mellitus	0.000264	0.0029	CbGpPWpGaD
Methsuximide—CYP2C19—Melatonin metabolism and effects—APOE—type 2 diabetes mellitus	0.000264	0.00289	CbGpPWpGaD
Methsuximide—Dizziness—Ramipril—type 2 diabetes mellitus	0.000261	0.000873	CcSEcCtD
Methsuximide—CACNA1G—Developmental Biology—TRPC6—type 2 diabetes mellitus	0.000258	0.00283	CbGpPWpGaD
Methsuximide—CACNA1H—Developmental Biology—GCK—type 2 diabetes mellitus	0.000258	0.00282	CbGpPWpGaD
Methsuximide—CACNA1H—Developmental Biology—IAPP—type 2 diabetes mellitus	0.000256	0.00281	CbGpPWpGaD
Methsuximide—Phenobarbital—CYP1A2—type 2 diabetes mellitus	0.000254	0.0301	CrCbGaD
Methsuximide—Vomiting—Ramipril—type 2 diabetes mellitus	0.000251	0.000839	CcSEcCtD
Methsuximide—CYP2C19—Biological oxidations—MAT1A—type 2 diabetes mellitus	0.000251	0.00275	CbGpPWpGaD
Methsuximide—CACNA1H—Corticotropin-releasing hormone—TGFB1—type 2 diabetes mellitus	0.00025	0.00274	CbGpPWpGaD
Methsuximide—CACNA1H—Developmental Biology—TRPC6—type 2 diabetes mellitus	0.00025	0.00274	CbGpPWpGaD
Methsuximide—Rash—Ramipril—type 2 diabetes mellitus	0.000249	0.000832	CcSEcCtD
Methsuximide—Dermatitis—Ramipril—type 2 diabetes mellitus	0.000249	0.000832	CcSEcCtD
Methsuximide—CACNA1G—NCAM signaling for neurite out-growth—IL6—type 2 diabetes mellitus	0.000248	0.00272	CbGpPWpGaD
Methsuximide—Headache—Ramipril—type 2 diabetes mellitus	0.000247	0.000827	CcSEcCtD
Methsuximide—CACNA1G—Developmental Biology—PAX6—type 2 diabetes mellitus	0.000247	0.00271	CbGpPWpGaD
Methsuximide—CACNA1I—Developmental Biology—PPARGC1A—type 2 diabetes mellitus	0.000242	0.00265	CbGpPWpGaD
Methsuximide—CACNA1H—NCAM signaling for neurite out-growth—IL6—type 2 diabetes mellitus	0.00024	0.00263	CbGpPWpGaD
Methsuximide—CACNA1H—Developmental Biology—PAX6—type 2 diabetes mellitus	0.000239	0.00262	CbGpPWpGaD
Methsuximide—CACNA1G—Developmental Biology—SREBF1—type 2 diabetes mellitus	0.000239	0.00261	CbGpPWpGaD
Methsuximide—Pethidine—CYP3A4—type 2 diabetes mellitus	0.000238	0.0283	CrCbGaD
Methsuximide—Ketazolam—ALB—type 2 diabetes mellitus	0.000238	0.0282	CrCbGaD
Methsuximide—CYP2C19—Cytochrome P450 - arranged by substrate type—CYP2E1—type 2 diabetes mellitus	0.000236	0.00259	CbGpPWpGaD
Methsuximide—Nausea—Ramipril—type 2 diabetes mellitus	0.000234	0.000784	CcSEcCtD
Methsuximide—CYP2C19—Cytochrome P450 - arranged by substrate type—CYP1A2—type 2 diabetes mellitus	0.000234	0.00256	CbGpPWpGaD
Methsuximide—CYP2C19—Oxidation by Cytochrome P450—CYP2E1—type 2 diabetes mellitus	0.000233	0.00256	CbGpPWpGaD
Methsuximide—CYP2C19—Phase 1 - Functionalization of compounds—CYP11A1—type 2 diabetes mellitus	0.000232	0.00254	CbGpPWpGaD
Methsuximide—CACNA1H—Developmental Biology—SREBF1—type 2 diabetes mellitus	0.000231	0.00253	CbGpPWpGaD
Methsuximide—CYP2C19—Oxidation by Cytochrome P450—CYP1A2—type 2 diabetes mellitus	0.000231	0.00253	CbGpPWpGaD
Methsuximide—CYP2C19—Cytochrome P450 - arranged by substrate type—CYP3A4—type 2 diabetes mellitus	0.000228	0.0025	CbGpPWpGaD
Methsuximide—CYP2C19—Oxidation by Cytochrome P450—CYP3A4—type 2 diabetes mellitus	0.000225	0.00247	CbGpPWpGaD
Methsuximide—CACNA1I—Developmental Biology—LPL—type 2 diabetes mellitus	0.00022	0.00241	CbGpPWpGaD
Methsuximide—CACNA1G—Developmental Biology—ADIPOQ—type 2 diabetes mellitus	0.000219	0.0024	CbGpPWpGaD
Methsuximide—CACNA1H—Developmental Biology—ADIPOQ—type 2 diabetes mellitus	0.000212	0.00233	CbGpPWpGaD
Methsuximide—CACNA1I—Developmental Biology—CD36—type 2 diabetes mellitus	0.000209	0.00229	CbGpPWpGaD
Methsuximide—Pethidine—ALB—type 2 diabetes mellitus	0.000208	0.0247	CrCbGaD
Methsuximide—CACNA1G—Developmental Biology—SLC2A4—type 2 diabetes mellitus	0.000207	0.00227	CbGpPWpGaD
Methsuximide—CACNA1H—Developmental Biology—SLC2A4—type 2 diabetes mellitus	0.0002	0.0022	CbGpPWpGaD
Methsuximide—CYP2C19—Arachidonic acid metabolism—GPX1—type 2 diabetes mellitus	0.000198	0.00218	CbGpPWpGaD
Methsuximide—CACNA1I—Developmental Biology—PPARA—type 2 diabetes mellitus	0.000194	0.00213	CbGpPWpGaD
Methsuximide—Clobazam—CYP3A4—type 2 diabetes mellitus	0.000192	0.0228	CrCbGaD
Methsuximide—CYP2C19—Phase 1 - Functionalization of compounds—CYP2E1—type 2 diabetes mellitus	0.000192	0.0021	CbGpPWpGaD
Methsuximide—CYP2C19—Phase 1 - Functionalization of compounds—CYP1A2—type 2 diabetes mellitus	0.000189	0.00208	CbGpPWpGaD
Methsuximide—CYP2C19—Phase 1 - Functionalization of compounds—CYP3A4—type 2 diabetes mellitus	0.000185	0.00203	CbGpPWpGaD
Methsuximide—CACNA1I—Developmental Biology—LEP—type 2 diabetes mellitus	0.000185	0.00202	CbGpPWpGaD
Methsuximide—CACNA1G—Developmental Biology—PPARGC1A—type 2 diabetes mellitus	0.000178	0.00195	CbGpPWpGaD
Methsuximide—Phenytoin—CYP3A4—type 2 diabetes mellitus	0.000175	0.0208	CrCbGaD
Methsuximide—CACNA1H—Corticotropin-releasing hormone—AKT1—type 2 diabetes mellitus	0.000174	0.00191	CbGpPWpGaD
Methsuximide—CACNA1H—Developmental Biology—PPARGC1A—type 2 diabetes mellitus	0.000173	0.00189	CbGpPWpGaD
Methsuximide—Phenobarbital—CYP3A4—type 2 diabetes mellitus	0.000168	0.02	CrCbGaD
Methsuximide—CACNA1G—Developmental Biology—LPL—type 2 diabetes mellitus	0.000162	0.00178	CbGpPWpGaD
Methsuximide—CACNA1I—Developmental Biology—PPARG—type 2 diabetes mellitus	0.000161	0.00176	CbGpPWpGaD
Methsuximide—CACNA1I—Developmental Biology—INS—type 2 diabetes mellitus	0.000158	0.00173	CbGpPWpGaD
Methsuximide—CACNA1H—Developmental Biology—LPL—type 2 diabetes mellitus	0.000157	0.00172	CbGpPWpGaD
Methsuximide—CYP2C19—Melatonin metabolism and effects—NFKB1—type 2 diabetes mellitus	0.000157	0.00172	CbGpPWpGaD
Methsuximide—CACNA1I—Axon guidance—MMP9—type 2 diabetes mellitus	0.000155	0.0017	CbGpPWpGaD
Methsuximide—CACNA1G—Developmental Biology—CD36—type 2 diabetes mellitus	0.000154	0.00169	CbGpPWpGaD
Methsuximide—Phenytoin—ALB—type 2 diabetes mellitus	0.000153	0.0182	CrCbGaD
Methsuximide—CACNA1I—Developmental Biology—AKT2—type 2 diabetes mellitus	0.000152	0.00167	CbGpPWpGaD
Methsuximide—CACNA1H—Developmental Biology—CD36—type 2 diabetes mellitus	0.000149	0.00164	CbGpPWpGaD
Methsuximide—CACNA1G—Developmental Biology—PPARA—type 2 diabetes mellitus	0.000143	0.00157	CbGpPWpGaD
Methsuximide—CACNA1I—Axon guidance—SRC—type 2 diabetes mellitus	0.000143	0.00157	CbGpPWpGaD
Methsuximide—CACNA1I—Axon guidance—VEGFA—type 2 diabetes mellitus	0.00014	0.00153	CbGpPWpGaD
Methsuximide—CACNA1H—Developmental Biology—PPARA—type 2 diabetes mellitus	0.000139	0.00152	CbGpPWpGaD
Methsuximide—CACNA1G—Developmental Biology—LEP—type 2 diabetes mellitus	0.000136	0.00149	CbGpPWpGaD
Methsuximide—CACNA1H—Developmental Biology—LEP—type 2 diabetes mellitus	0.000132	0.00144	CbGpPWpGaD
Methsuximide—CACNA1I—Developmental Biology—RELA—type 2 diabetes mellitus	0.00013	0.00143	CbGpPWpGaD
Methsuximide—CYP2C19—Biological oxidations—MTR—type 2 diabetes mellitus	0.000127	0.0014	CbGpPWpGaD
Methsuximide—CACNA1I—Axon guidance—EGFR—type 2 diabetes mellitus	0.000126	0.00138	CbGpPWpGaD
Methsuximide—CYP2C19—Biological oxidations—CYP11A1—type 2 diabetes mellitus	0.000123	0.00135	CbGpPWpGaD
Methsuximide—CYP2C19—Metapathway biotransformation—CYP11A1—type 2 diabetes mellitus	0.000122	0.00133	CbGpPWpGaD
Methsuximide—CACNA1G—Developmental Biology—PPARG—type 2 diabetes mellitus	0.000118	0.0013	CbGpPWpGaD
Methsuximide—CYP2C19—Arachidonic acid metabolism—PTGS2—type 2 diabetes mellitus	0.000117	0.00128	CbGpPWpGaD
Methsuximide—CACNA1G—Developmental Biology—INS—type 2 diabetes mellitus	0.000116	0.00127	CbGpPWpGaD
Methsuximide—CYP2C19—Metabolism of lipids and lipoproteins—PTGDS—type 2 diabetes mellitus	0.000115	0.00127	CbGpPWpGaD
Methsuximide—CACNA1H—Developmental Biology—PPARG—type 2 diabetes mellitus	0.000115	0.00126	CbGpPWpGaD
Methsuximide—CACNA1G—Axon guidance—MMP9—type 2 diabetes mellitus	0.000115	0.00126	CbGpPWpGaD
Methsuximide—CACNA1H—Developmental Biology—INS—type 2 diabetes mellitus	0.000113	0.00123	CbGpPWpGaD
Methsuximide—CACNA1G—Developmental Biology—AKT2—type 2 diabetes mellitus	0.000112	0.00123	CbGpPWpGaD
Methsuximide—CACNA1H—Axon guidance—MMP9—type 2 diabetes mellitus	0.000111	0.00122	CbGpPWpGaD
Methsuximide—CACNA1I—Developmental Biology—MMP9—type 2 diabetes mellitus	0.000111	0.00122	CbGpPWpGaD
Methsuximide—CACNA1I—Developmental Biology—NFKB1—type 2 diabetes mellitus	0.00011	0.0012	CbGpPWpGaD
Methsuximide—CYP2C19—Metabolism of lipids and lipoproteins—GPD2—type 2 diabetes mellitus	0.000109	0.0012	CbGpPWpGaD
Methsuximide—CACNA1H—Developmental Biology—AKT2—type 2 diabetes mellitus	0.000109	0.00119	CbGpPWpGaD
Methsuximide—CACNA1G—Axon guidance—SRC—type 2 diabetes mellitus	0.000106	0.00116	CbGpPWpGaD
Methsuximide—CACNA1G—Axon guidance—VEGFA—type 2 diabetes mellitus	0.000103	0.00113	CbGpPWpGaD
Methsuximide—CACNA1H—Axon guidance—SRC—type 2 diabetes mellitus	0.000102	0.00112	CbGpPWpGaD
Methsuximide—CACNA1I—Developmental Biology—SRC—type 2 diabetes mellitus	0.000102	0.00112	CbGpPWpGaD
Methsuximide—CYP2C19—Biological oxidations—CYP2E1—type 2 diabetes mellitus	0.000102	0.00112	CbGpPWpGaD
Methsuximide—CYP2C19—Biological oxidations—CYP1A2—type 2 diabetes mellitus	0.000101	0.0011	CbGpPWpGaD
Methsuximide—CYP2C19—Metapathway biotransformation—CYP2E1—type 2 diabetes mellitus	0.0001	0.0011	CbGpPWpGaD
Methsuximide—CACNA1H—Axon guidance—VEGFA—type 2 diabetes mellitus	9.96e-05	0.00109	CbGpPWpGaD
Methsuximide—CACNA1I—Developmental Biology—VEGFA—type 2 diabetes mellitus	9.96e-05	0.00109	CbGpPWpGaD
Methsuximide—CYP2C19—Metapathway biotransformation—CYP1A2—type 2 diabetes mellitus	9.93e-05	0.00109	CbGpPWpGaD
Methsuximide—CYP2C19—Biological oxidations—CYP3A4—type 2 diabetes mellitus	9.82e-05	0.00108	CbGpPWpGaD
Methsuximide—CYP2C19—Metapathway biotransformation—CYP3A4—type 2 diabetes mellitus	9.68e-05	0.00106	CbGpPWpGaD
Methsuximide—CACNA1I—Axon guidance—IL6—type 2 diabetes mellitus	9.65e-05	0.00106	CbGpPWpGaD
Methsuximide—CACNA1G—Developmental Biology—RELA—type 2 diabetes mellitus	9.59e-05	0.00105	CbGpPWpGaD
Methsuximide—CACNA1H—Developmental Biology—RELA—type 2 diabetes mellitus	9.29e-05	0.00102	CbGpPWpGaD
Methsuximide—CACNA1G—Axon guidance—EGFR—type 2 diabetes mellitus	9.26e-05	0.00101	CbGpPWpGaD
Methsuximide—CACNA1I—Developmental Biology—TGFB1—type 2 diabetes mellitus	9.14e-05	0.001	CbGpPWpGaD
Methsuximide—CACNA1H—Axon guidance—EGFR—type 2 diabetes mellitus	8.97e-05	0.000983	CbGpPWpGaD
Methsuximide—CACNA1I—Developmental Biology—EGFR—type 2 diabetes mellitus	8.96e-05	0.000982	CbGpPWpGaD
Methsuximide—CACNA1I—Developmental Biology—TNF—type 2 diabetes mellitus	8.53e-05	0.000936	CbGpPWpGaD
Methsuximide—CYP2C19—Metabolism of lipids and lipoproteins—OXCT1—type 2 diabetes mellitus	8.51e-05	0.000933	CbGpPWpGaD
Methsuximide—CYP2C19—Metabolism of lipids and lipoproteins—SRD5A1—type 2 diabetes mellitus	8.3e-05	0.000909	CbGpPWpGaD
Methsuximide—CACNA1G—Developmental Biology—MMP9—type 2 diabetes mellitus	8.18e-05	0.000896	CbGpPWpGaD
Methsuximide—CACNA1G—Developmental Biology—NFKB1—type 2 diabetes mellitus	8.09e-05	0.000887	CbGpPWpGaD
Methsuximide—CACNA1H—Developmental Biology—MMP9—type 2 diabetes mellitus	7.92e-05	0.000868	CbGpPWpGaD
Methsuximide—CYP2C19—Metabolism of lipids and lipoproteins—HSD17B3—type 2 diabetes mellitus	7.91e-05	0.000868	CbGpPWpGaD
Methsuximide—CYP2C19—Metabolism of lipids and lipoproteins—STAR—type 2 diabetes mellitus	7.91e-05	0.000868	CbGpPWpGaD
Methsuximide—CYP2C19—Metabolism of lipids and lipoproteins—ACACA—type 2 diabetes mellitus	7.91e-05	0.000868	CbGpPWpGaD
Methsuximide—CACNA1H—Developmental Biology—NFKB1—type 2 diabetes mellitus	7.83e-05	0.000859	CbGpPWpGaD
Methsuximide—CYP2C19—Biological oxidations—GSTM1—type 2 diabetes mellitus	7.71e-05	0.000846	CbGpPWpGaD
Methsuximide—CYP2C19—Metapathway biotransformation—GSTM1—type 2 diabetes mellitus	7.61e-05	0.000834	CbGpPWpGaD
Methsuximide—CACNA1G—Developmental Biology—SRC—type 2 diabetes mellitus	7.54e-05	0.000826	CbGpPWpGaD
Methsuximide—CACNA1G—Developmental Biology—VEGFA—type 2 diabetes mellitus	7.34e-05	0.000805	CbGpPWpGaD
Methsuximide—CACNA1H—Developmental Biology—SRC—type 2 diabetes mellitus	7.3e-05	0.0008	CbGpPWpGaD
Methsuximide—CYP2C19—Metabolism of lipids and lipoproteins—NCOA6—type 2 diabetes mellitus	7.17e-05	0.000787	CbGpPWpGaD
Methsuximide—CACNA1G—Axon guidance—IL6—type 2 diabetes mellitus	7.12e-05	0.00078	CbGpPWpGaD
Methsuximide—CACNA1H—Developmental Biology—VEGFA—type 2 diabetes mellitus	7.11e-05	0.000779	CbGpPWpGaD
Methsuximide—CYP2C19—Metabolism of lipids and lipoproteins—HSD11B1—type 2 diabetes mellitus	7.05e-05	0.000773	CbGpPWpGaD
Methsuximide—CACNA1H—Axon guidance—IL6—type 2 diabetes mellitus	6.89e-05	0.000755	CbGpPWpGaD
Methsuximide—CACNA1I—Developmental Biology—IL6—type 2 diabetes mellitus	6.89e-05	0.000755	CbGpPWpGaD
Methsuximide—CACNA1G—Developmental Biology—TGFB1—type 2 diabetes mellitus	6.74e-05	0.000739	CbGpPWpGaD
Methsuximide—CACNA1G—Developmental Biology—EGFR—type 2 diabetes mellitus	6.61e-05	0.000724	CbGpPWpGaD
Methsuximide—CACNA1H—Developmental Biology—TGFB1—type 2 diabetes mellitus	6.53e-05	0.000715	CbGpPWpGaD
Methsuximide—CACNA1H—Developmental Biology—EGFR—type 2 diabetes mellitus	6.4e-05	0.000701	CbGpPWpGaD
Methsuximide—CACNA1I—Developmental Biology—AKT1—type 2 diabetes mellitus	6.35e-05	0.000697	CbGpPWpGaD
Methsuximide—CACNA1G—Developmental Biology—TNF—type 2 diabetes mellitus	6.29e-05	0.00069	CbGpPWpGaD
Methsuximide—CACNA1H—Developmental Biology—TNF—type 2 diabetes mellitus	6.09e-05	0.000668	CbGpPWpGaD
Methsuximide—CYP2C19—Metabolism of lipids and lipoproteins—HSD3B2—type 2 diabetes mellitus	6e-05	0.000658	CbGpPWpGaD
Methsuximide—CYP2C19—Metabolism of lipids and lipoproteins—LPA—type 2 diabetes mellitus	6e-05	0.000658	CbGpPWpGaD
Methsuximide—CYP2C19—Metabolism—BHMT—type 2 diabetes mellitus	5.88e-05	0.000645	CbGpPWpGaD
Methsuximide—CYP2C19—Metabolism—PTGDS—type 2 diabetes mellitus	5.14e-05	0.000564	CbGpPWpGaD
Methsuximide—CYP2C19—Metabolism—AANAT—type 2 diabetes mellitus	5.14e-05	0.000564	CbGpPWpGaD
Methsuximide—CACNA1G—Developmental Biology—IL6—type 2 diabetes mellitus	5.08e-05	0.000557	CbGpPWpGaD
Methsuximide—CACNA1H—Developmental Biology—IL6—type 2 diabetes mellitus	4.92e-05	0.000539	CbGpPWpGaD
Methsuximide—CYP2C19—Metabolism of lipids and lipoproteins—CPT1A—type 2 diabetes mellitus	4.89e-05	0.000536	CbGpPWpGaD
Methsuximide—CYP2C19—Metabolism—CDO1—type 2 diabetes mellitus	4.87e-05	0.000534	CbGpPWpGaD
Methsuximide—CYP2C19—Metabolism—GPD2—type 2 diabetes mellitus	4.87e-05	0.000534	CbGpPWpGaD
Methsuximide—CYP2C19—Metabolism of lipids and lipoproteins—LIPC—type 2 diabetes mellitus	4.76e-05	0.000522	CbGpPWpGaD
Methsuximide—CYP2C19—Metabolism of lipids and lipoproteins—CYP11A1—type 2 diabetes mellitus	4.74e-05	0.000519	CbGpPWpGaD
Methsuximide—CACNA1G—Developmental Biology—AKT1—type 2 diabetes mellitus	4.68e-05	0.000514	CbGpPWpGaD
Methsuximide—CYP2C19—Metabolism—AK1—type 2 diabetes mellitus	4.65e-05	0.00051	CbGpPWpGaD
Methsuximide—CYP2C19—Metabolism of lipids and lipoproteins—CETP—type 2 diabetes mellitus	4.6e-05	0.000504	CbGpPWpGaD
Methsuximide—CACNA1H—Developmental Biology—AKT1—type 2 diabetes mellitus	4.54e-05	0.000497	CbGpPWpGaD
Methsuximide—CYP2C19—Metabolism—MAT1A—type 2 diabetes mellitus	4.29e-05	0.000471	CbGpPWpGaD
Methsuximide—CYP2C19—Metabolism—SLC5A4—type 2 diabetes mellitus	4.29e-05	0.000471	CbGpPWpGaD
Methsuximide—CYP2C19—Metabolism of lipids and lipoproteins—SREBF1—type 2 diabetes mellitus	4.27e-05	0.000469	CbGpPWpGaD
Methsuximide—CYP2C19—Metabolism of lipids and lipoproteins—CTGF—type 2 diabetes mellitus	4.19e-05	0.00046	CbGpPWpGaD
Methsuximide—CYP2C19—Metabolism of lipids and lipoproteins—HMGCR—type 2 diabetes mellitus	4.16e-05	0.000456	CbGpPWpGaD
Methsuximide—CYP2C19—Metabolism—ND1—type 2 diabetes mellitus	4.15e-05	0.000454	CbGpPWpGaD
Methsuximide—CYP2C19—Metabolism—G6PC—type 2 diabetes mellitus	4.15e-05	0.000454	CbGpPWpGaD
Methsuximide—CYP2C19—Metabolism—HBA2—type 2 diabetes mellitus	4.15e-05	0.000454	CbGpPWpGaD
Methsuximide—CYP2C19—Metabolism—ENPP1—type 2 diabetes mellitus	4.15e-05	0.000454	CbGpPWpGaD
Methsuximide—CYP2C19—Metabolism—PPP1R3C—type 2 diabetes mellitus	4.15e-05	0.000454	CbGpPWpGaD
Methsuximide—CYP2C19—Metabolism—GCGR—type 2 diabetes mellitus	4.01e-05	0.00044	CbGpPWpGaD
Methsuximide—CYP2C19—Metabolism of lipids and lipoproteins—CYP1A2—type 2 diabetes mellitus	3.86e-05	0.000424	CbGpPWpGaD
Methsuximide—CYP2C19—Metabolism—OXCT1—type 2 diabetes mellitus	3.79e-05	0.000416	CbGpPWpGaD
Methsuximide—CYP2C19—Metabolism—CYTB—type 2 diabetes mellitus	3.79e-05	0.000416	CbGpPWpGaD
Methsuximide—CYP2C19—Metabolism—SRD5A1—type 2 diabetes mellitus	3.69e-05	0.000405	CbGpPWpGaD
Methsuximide—CYP2C19—Metabolism—HSD17B3—type 2 diabetes mellitus	3.52e-05	0.000386	CbGpPWpGaD
Methsuximide—CYP2C19—Metabolism—ACACA—type 2 diabetes mellitus	3.52e-05	0.000386	CbGpPWpGaD
Methsuximide—CYP2C19—Metabolism—STAR—type 2 diabetes mellitus	3.52e-05	0.000386	CbGpPWpGaD
Methsuximide—CYP2C19—Metabolism—CBS—type 2 diabetes mellitus	3.38e-05	0.00037	CbGpPWpGaD
Methsuximide—CYP2C19—Metabolism—ABCC8—type 2 diabetes mellitus	3.38e-05	0.00037	CbGpPWpGaD
Methsuximide—CYP2C19—Metabolism—SLC5A2—type 2 diabetes mellitus	3.25e-05	0.000357	CbGpPWpGaD
Methsuximide—CYP2C19—Metabolism—COX2—type 2 diabetes mellitus	3.25e-05	0.000357	CbGpPWpGaD
Methsuximide—CYP2C19—Metabolism—NCOA6—type 2 diabetes mellitus	3.2e-05	0.00035	CbGpPWpGaD
Methsuximide—CYP2C19—Metabolism of lipids and lipoproteins—PPARGC1A—type 2 diabetes mellitus	3.19e-05	0.00035	CbGpPWpGaD
Methsuximide—CYP2C19—Metabolism—UCP2—type 2 diabetes mellitus	3.14e-05	0.000344	CbGpPWpGaD
Methsuximide—CYP2C19—Metabolism—HSD11B1—type 2 diabetes mellitus	3.14e-05	0.000344	CbGpPWpGaD
Methsuximide—CYP2C19—Metabolism—UCP3—type 2 diabetes mellitus	3.14e-05	0.000344	CbGpPWpGaD
Methsuximide—CYP2C19—Metabolism of lipids and lipoproteins—APOB—type 2 diabetes mellitus	3.05e-05	0.000334	CbGpPWpGaD
Methsuximide—CYP2C19—Metabolism—PCK1—type 2 diabetes mellitus	2.95e-05	0.000324	CbGpPWpGaD
Methsuximide—CYP2C19—Metabolism of lipids and lipoproteins—LPL—type 2 diabetes mellitus	2.91e-05	0.000319	CbGpPWpGaD
Methsuximide—CYP2C19—Metabolism of lipids and lipoproteins—GPX1—type 2 diabetes mellitus	2.84e-05	0.000311	CbGpPWpGaD
Methsuximide—CYP2C19—Metabolism—HK1—type 2 diabetes mellitus	2.77e-05	0.000303	CbGpPWpGaD
Methsuximide—CYP2C19—Metabolism of lipids and lipoproteins—CD36—type 2 diabetes mellitus	2.76e-05	0.000303	CbGpPWpGaD
Methsuximide—CYP2C19—Metabolism—KCNJ11—type 2 diabetes mellitus	2.67e-05	0.000293	CbGpPWpGaD
Methsuximide—CYP2C19—Metabolism—HSD3B2—type 2 diabetes mellitus	2.67e-05	0.000293	CbGpPWpGaD
Methsuximide—CYP2C19—Metabolism—GCKR—type 2 diabetes mellitus	2.67e-05	0.000293	CbGpPWpGaD
Methsuximide—CYP2C19—Metabolism—LPA—type 2 diabetes mellitus	2.67e-05	0.000293	CbGpPWpGaD
Methsuximide—CYP2C19—Metabolism of lipids and lipoproteins—PPARA—type 2 diabetes mellitus	2.57e-05	0.000282	CbGpPWpGaD
Methsuximide—CYP2C19—Metabolism—ALDOB—type 2 diabetes mellitus	2.56e-05	0.000281	CbGpPWpGaD
Methsuximide—CYP2C19—Metabolism of lipids and lipoproteins—AGT—type 2 diabetes mellitus	2.49e-05	0.000273	CbGpPWpGaD
Methsuximide—CYP2C19—Metabolism of lipids and lipoproteins—APOE—type 2 diabetes mellitus	2.44e-05	0.000267	CbGpPWpGaD
Methsuximide—CYP2C19—Metabolism of lipids and lipoproteins—APOA1—type 2 diabetes mellitus	2.41e-05	0.000264	CbGpPWpGaD
Methsuximide—CYP2C19—Metabolism—GLP1R—type 2 diabetes mellitus	2.38e-05	0.000261	CbGpPWpGaD
Methsuximide—CYP2C19—Metabolism—SLC2A2—type 2 diabetes mellitus	2.22e-05	0.000244	CbGpPWpGaD
Methsuximide—CYP2C19—Metabolism—CPT1A—type 2 diabetes mellitus	2.18e-05	0.000239	CbGpPWpGaD
Methsuximide—CYP2C19—Metabolism—MTR—type 2 diabetes mellitus	2.18e-05	0.000239	CbGpPWpGaD
Methsuximide—CYP2C19—Metabolism—NAMPT—type 2 diabetes mellitus	2.14e-05	0.000234	CbGpPWpGaD
Methsuximide—CYP2C19—Metabolism of lipids and lipoproteins—PPARG—type 2 diabetes mellitus	2.12e-05	0.000233	CbGpPWpGaD
Methsuximide—CYP2C19—Metabolism—GCK—type 2 diabetes mellitus	2.12e-05	0.000233	CbGpPWpGaD
Methsuximide—CYP2C19—Metabolism—HBA1—type 2 diabetes mellitus	2.12e-05	0.000233	CbGpPWpGaD
Methsuximide—CYP2C19—Metabolism—LIPC—type 2 diabetes mellitus	2.12e-05	0.000233	CbGpPWpGaD
Methsuximide—CYP2C19—Metabolism—CYP11A1—type 2 diabetes mellitus	2.11e-05	0.000231	CbGpPWpGaD
Methsuximide—CYP2C19—Metabolism—SLC9A1—type 2 diabetes mellitus	2.07e-05	0.000227	CbGpPWpGaD
Methsuximide—CYP2C19—Metabolism—CETP—type 2 diabetes mellitus	2.05e-05	0.000224	CbGpPWpGaD
Methsuximide—CYP2C19—Metabolism of lipids and lipoproteins—ALB—type 2 diabetes mellitus	1.91e-05	0.000209	CbGpPWpGaD
Methsuximide—CYP2C19—Metabolism—SNAP25—type 2 diabetes mellitus	1.9e-05	0.000209	CbGpPWpGaD
Methsuximide—CYP2C19—Metabolism—SREBF1—type 2 diabetes mellitus	1.9e-05	0.000209	CbGpPWpGaD
Methsuximide—CYP2C19—Metabolism—PSMD6—type 2 diabetes mellitus	1.9e-05	0.000209	CbGpPWpGaD
Methsuximide—CYP2C19—Metabolism—CTGF—type 2 diabetes mellitus	1.87e-05	0.000205	CbGpPWpGaD
Methsuximide—CYP2C19—Metabolism—HMGCR—type 2 diabetes mellitus	1.85e-05	0.000203	CbGpPWpGaD
Methsuximide—CYP2C19—Metabolism of lipids and lipoproteins—PIK3R1—type 2 diabetes mellitus	1.83e-05	0.0002	CbGpPWpGaD
Methsuximide—CYP2C19—Metabolism—ADRA2A—type 2 diabetes mellitus	1.81e-05	0.000199	CbGpPWpGaD
Methsuximide—CYP2C19—Metabolism—CYP2E1—type 2 diabetes mellitus	1.74e-05	0.000191	CbGpPWpGaD
Methsuximide—CYP2C19—Metabolism—SLC2A1—type 2 diabetes mellitus	1.72e-05	0.000189	CbGpPWpGaD
Methsuximide—CYP2C19—Metabolism—CYP1A2—type 2 diabetes mellitus	1.72e-05	0.000189	CbGpPWpGaD
Methsuximide—CYP2C19—Metabolism—CYP3A4—type 2 diabetes mellitus	1.68e-05	0.000184	CbGpPWpGaD
Methsuximide—CYP2C19—Metabolism of lipids and lipoproteins—PTGS2—type 2 diabetes mellitus	1.67e-05	0.000183	CbGpPWpGaD
Methsuximide—CYP2C19—Metabolism—SLC2A4—type 2 diabetes mellitus	1.65e-05	0.000181	CbGpPWpGaD
Methsuximide—CYP2C19—Metabolism—GCG—type 2 diabetes mellitus	1.65e-05	0.000181	CbGpPWpGaD
Methsuximide—CYP2C19—Metabolism—GNB3—type 2 diabetes mellitus	1.42e-05	0.000156	CbGpPWpGaD
Methsuximide—CYP2C19—Metabolism—PPARGC1A—type 2 diabetes mellitus	1.42e-05	0.000156	CbGpPWpGaD
Methsuximide—CYP2C19—Metabolism—HMOX1—type 2 diabetes mellitus	1.42e-05	0.000155	CbGpPWpGaD
Methsuximide—CYP2C19—Metabolism—CAT—type 2 diabetes mellitus	1.4e-05	0.000153	CbGpPWpGaD
Methsuximide—CYP2C19—Metabolism—APOB—type 2 diabetes mellitus	1.36e-05	0.000149	CbGpPWpGaD
Methsuximide—CYP2C19—Metabolism—GSTM1—type 2 diabetes mellitus	1.32e-05	0.000145	CbGpPWpGaD
Methsuximide—CYP2C19—Metabolism—LPL—type 2 diabetes mellitus	1.29e-05	0.000142	CbGpPWpGaD
Methsuximide—CYP2C19—Metabolism—ADCY5—type 2 diabetes mellitus	1.27e-05	0.000139	CbGpPWpGaD
Methsuximide—CYP2C19—Metabolism—GPX1—type 2 diabetes mellitus	1.26e-05	0.000138	CbGpPWpGaD
Methsuximide—CYP2C19—Metabolism—CD36—type 2 diabetes mellitus	1.23e-05	0.000135	CbGpPWpGaD
Methsuximide—CYP2C19—Metabolism—PPP2CA—type 2 diabetes mellitus	1.21e-05	0.000133	CbGpPWpGaD
Methsuximide—CYP2C19—Metabolism—MTHFR—type 2 diabetes mellitus	1.17e-05	0.000128	CbGpPWpGaD
Methsuximide—CYP2C19—Metabolism—PPARA—type 2 diabetes mellitus	1.14e-05	0.000125	CbGpPWpGaD
Methsuximide—CYP2C19—Metabolism—AGT—type 2 diabetes mellitus	1.11e-05	0.000121	CbGpPWpGaD
Methsuximide—CYP2C19—Metabolism—CALM1—type 2 diabetes mellitus	1.09e-05	0.000119	CbGpPWpGaD
Methsuximide—CYP2C19—Metabolism—APOE—type 2 diabetes mellitus	1.09e-05	0.000119	CbGpPWpGaD
Methsuximide—CYP2C19—Metabolism—APOA1—type 2 diabetes mellitus	1.07e-05	0.000118	CbGpPWpGaD
Methsuximide—CYP2C19—Metabolism—PPARG—type 2 diabetes mellitus	9.45e-06	0.000104	CbGpPWpGaD
Methsuximide—CYP2C19—Metabolism—INS—type 2 diabetes mellitus	9.27e-06	0.000102	CbGpPWpGaD
Methsuximide—CYP2C19—Metabolism—ALB—type 2 diabetes mellitus	8.5e-06	9.32e-05	CbGpPWpGaD
Methsuximide—CYP2C19—Metabolism—NOS3—type 2 diabetes mellitus	8.13e-06	8.91e-05	CbGpPWpGaD
Methsuximide—CYP2C19—Metabolism—PIK3R1—type 2 diabetes mellitus	8.13e-06	8.91e-05	CbGpPWpGaD
Methsuximide—CYP2C19—Metabolism—PTGS2—type 2 diabetes mellitus	7.44e-06	8.15e-05	CbGpPWpGaD
Methsuximide—CYP2C19—Metabolism—AKT1—type 2 diabetes mellitus	3.74e-06	4.1e-05	CbGpPWpGaD
